Drug Topics

Vaccines, Variants, and More: COVID-19 Year in Review

Mar 26, 2023

Lauren Biscaldi, Managing Editor

Conferences|APhA Annual Meeting & Exposition

From variants to vaccines, much has changed in the COVID-19 landscape.

Jacinda C. Abdul-Mutakabbir, PharmD, MPH, AAHIVP, Assistant Professor of Clinical Pharmacy at the University of California, San Diego, sat down with Drug Topics at the APhA 2023 Annual Meeting to review some the most crucial COVID-19 updates from 2022.

Related Videos

fake news misinformation | Image Credit: Bits and Splits - stock.adobe.com

Related Content

Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID

Podcast: Your ThoughtSpot 2022 Day 2 Recap

FDA: Pfizer RSV Vaccine Approved for Use In Older Adults

Podcast: What You Missed at ThoughtSpot 2022 Day 1

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD

Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID

Podcast: Your ThoughtSpot 2022 Day 2 Recap

FDA: Pfizer RSV Vaccine Approved for Use In Older Adults

Podcast: What You Missed at ThoughtSpot 2022 Day 1

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD

Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID

Podcast: Your ThoughtSpot 2022 Day 2 Recap

FDA: Pfizer RSV Vaccine Approved for Use In Older Adults

Podcast: What You Missed at ThoughtSpot 2022 Day 1

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD

Related Content

Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID

Exploring the Link Between Reduced Exercise Capacity and Cardiopulmonary Symptoms in Long COVID

New research suggests that chronotropic incompetence contributes to exercise limitations in Long COVID.

Podcast: Your ThoughtSpot 2022 Day 2 Recap

Podcast: Your ThoughtSpot 2022 Day 2 Recap

From the Pharmacy of the Year winner announcement to a powerful Women in Pharmacy Workshop, here's what you missed on day 2 of ThoughtSpot.

FDA: Pfizer RSV Vaccine Approved for Use In Older Adults

FDA: Pfizer RSV Vaccine Approved for Use In Older Adults

Abrysvo is the second RSV vaccine approved by the FDA.

Podcast: What You Missed at ThoughtSpot 2022 Day 1

Podcast: What You Missed at ThoughtSpot 2022 Day 1

The Drug Topics® team is on the ground at ThoughtSpot 2022. Here's what you missed on Day 1.

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

First Oral Antiviral Treatment For COVID-19 Gets FDA Approval

More than 11.6 million treatment courses of the medication have been prescribed in the U.S. to date.

How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD

How Biologic Therapy Can Help Mitigate COVID-Related Complications In Patients With IBD

New data from Digestive Disease Week furthers evidence that biologics can be effective

Terms and Conditions

Do Not Sell My Personal Information

Contact Info

2 Clarke Drive
Cranbury, NJ 08512

© 2023 MJH Life Sciences

All rights reserved.